CA1038707A - Biocompatible carbon prosthetic devices - Google Patents

Biocompatible carbon prosthetic devices

Info

Publication number
CA1038707A
CA1038707A CA231,336A CA231336A CA1038707A CA 1038707 A CA1038707 A CA 1038707A CA 231336 A CA231336 A CA 231336A CA 1038707 A CA1038707 A CA 1038707A
Authority
CA
Canada
Prior art keywords
carbon
polymer
accordance
prosthetic device
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA231,336A
Other languages
French (fr)
Inventor
Jack C. Bokros
Jere B. Horsley (Jr.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Atomics Corp
Original Assignee
General Atomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Atomics Corp filed Critical General Atomics Corp
Application granted granted Critical
Publication of CA1038707A publication Critical patent/CA1038707A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/02Use of inorganic materials
    • A61L33/025Carbon; Graphite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials

Abstract

ABSTRACT
A biocompatible prosthetic device comprising a metal alloy substrate, an intermediate layer of a high-temperature polymer which is strongly bonded thereto, and an exterior coating of dense vapor-deposited carbon. The carbon layer is thromboresistant and strongly adheres to the intermediate layer which in turn strongly adheres to the metal alloy.
The polymer may be the reaction product of pyromelletic dianhydride and a diaminodiphenyl ether, and the carbon may be deposited under high vacuum conditions from a suitably heated carbon source, e.g., by ion-plating or vacuum vapor deposition.

Description

This invention reIates to prosthetic devices ~nd ~, more particularly to the manufacture of prosthetic devices and/or parts therefor utilizing metal substrates by applying '' strongly adherent, biocompatible carbon coatings thereupon.
The employment of pyrolytic carbon coatings to ~ -~
produce biocompatible and thromboresistant surfaces for prosthetic devices is known and is described in Bokros, et al.
U.S. Patent No. 3,526,005,,issued September 1, 1970, and Bokros,,et al. No. 3,685,059, issued August 22, 1972, which 10 patents generally describe such deposition of pyrolytic carbon ~', ,'',;
coatings, usually from a diluted hydrocarbon,a-tmosphere at atmospheric,pressure. Various other techniques' have been ~ Y' developed for depositing carbon coatlngs~,for example as by vacuum vapor deposition (W D) which is also somet:imes referred ;' ,~
~` 15 to as vacuum metalizi'ng or physical vapor deposition or evapora~
tive coating. Coatings deposited by such ~WD techniques show promise as coatings for pros~hetic,devices; however, when certain substrate materials are coated,,the resultant bond between coating and substrate has not been in all-respects 20~ satis~actory. Accordingly, methods of applying more adherent carbon coatings of this general type are desired. '~
It is the object of the present ,invention to provide a method of making prosthetic devices having strongly adherent, , `' vapor-deposited carbon coatings. A further object of the ',~' invention is to provide prosthetic devices having strongly adherent,,biocompatible and thromboresistant carbon coatings. '~
Still another object is to provide a methbd for producing ~' prosthetic devices using WD techniques which have biocompatible - ~, and thromboresistant carbon-coated exterior surfaces.
' The above objects are met by the present invention which provides a ~ethod of making a biocompatible prosthetic , ',; ' ' , . ;';'"~"':'!t ",; ~: .

103B7~7 device comprising precoating a metal alloy substrate with an organic high-temperature polymer to provide a strongly ad- -herent, continuous intermediat~ layer, and then applying carbon from a vaporous atmosphexe to the precoated substrate to deposit a continuous, dense, thromboresistant carbon coating at least about lOOOA thick upon the intermediate layer. .. -`~
Practice of the above method results in a biocom- .~:
patible prosthetic device comprising a metal alloy substrate, an intermediate continuous layer of an organic high-temperature polymer which is strongly bonded thereto, and an exterior in-situ-deposited coating of continuous, dense vapor-deposited carbon at least lOOOA thick, whi:ch carbon layer is biocom~
patible and stxongly adherent to the intermediate layer.
The invention will be readily apparent from a reading o~ the following detailed description of several preferred methods , ' ;~.
,'` ' ~ ' :, ' '"

-la-,, - ; , for making prosthetic devices embodytng various aspects of the invention.
It has been found that substrates, particularly certain metal alloys, to which vapor-deposited carbon cannot be readily adhered as a uniform continuous layer, can be first pre-coated with an organic polymer, such as a high molecular weight linear pol~mer or suitable precursor of a thermosetting polymer. Once the polymer is set to provide an intermediate layer, a uniform, strongly adherent carbon coating can be deposited thereon to create a prosthetic device. The various so-called "high-temperature polymers" which have generally been developed in the last decade are preferred, and generally those resins with the highest softening points are the most preferred. The particularly preferred class of these polymers are polyimides which can be applied as a solution and then cured ln situ to form an infusible polymer. For purposes of this application, the term prosthetic device is intended to include not only bone, intravascular~ and valve pxostheses, -and parts thereof, but also includes parts for extracorporeal devices which will be in contact with the bloodstream of a -~
,: ,-. , , living person, for example, circulatory assist devices and the like.
. ~ , ,-, Various metal alloysr for example stainless steeis, cobalt alloys such as Haynes alloy number 25 and VITALLIUM
(trade mark), and the like, show sufficient corrosion resistance ~ ~
to permit their use in the construction of prosthetic devices. ~ ' -Moreover, such metal alloys have the desired tensile strength for applications where such strength is needed, for example, in bone repair or replacement and the like. However, problems have developed with the compatibility of these alloys and the body organs, tissue and blood with which they would come into contact i~ used in the construction of prosthetic devices.

' ' ,,, ' .

~ \ ~

However, carbon, the organic building block for al} body matter, has shown outstanding tissue and blood compatibility for a variety of prosthetic device applications. By the present pre-coating method, these corrosion-resistant metal alloys can now be provided, by ion-platlng or VVD coating techniques, with strongly adherent carbon coatings.
It has been found that certain high-temperature ~ -polymer layers can be applied to these corrosion-resista~t metal alloys which will strongly bond thereto when cured ln situ. As a result, an intermediate layer is provided which is excellently receptive to the vapor deposition thereupon of a dense, biocompatible carbon layer. The polymer solution may be applied in any suitable manner, as by dipping, spraying, painting, or the like~ which provides a smooth surface. The polymer chosen will normally be soluble in an organic solvent ;~
so that it can be applied as a~ uid solution. In the preferred case of a polyimide, the solvent is preferably ,.:
removed prior to the ln situ curing to form the infusible polyrner. By the initial removal of the solvent, a thin surface ~ilm forms prior to the creation o~ the final, infusible polymer, and smoother resultant surface is obtained. ;~
These high-t~nperature polyrnere exhibit thermal stability at temperatures of 300C. and higher and are generally characterized as linear, high molecular weight, aromatic, nitrogen-linked polymers Exarnples o~ such high-temperature polyrners include~; or~dered aromatic copolyamides, suah as the reaction product o~ phenylenebis (~nino-benzamide) and isophthaloyl chloride, all-aromatic polybenzimidazoles, such as poly ~2,2' (m~phenylene)-5,5l(6,6' benzimidazole)], polyoxadiazoles, poly(N-phenyl triazoles), polybenzobenzimid-azoles, polyimides and poly(amide-imide) resins.

, ', ' , . '~ ' :, ' , ', ,,, ' " ':

71~7 The preferred polymers are polyimide and poly (amide-imide) resins. Polyimides are predicated upon the initial condensation reaction between an aromatic diamlne, such as a diaminophenyl ether, with an aromatic dianhydride, such as pyromelletic dianhydride. The resultant, tractable polyamic acid is converted, during final cure, to an infusible, insoluble and intractable polyimide as a result of the loss of water. The polyimides can be applied in the form of the tractable polyamic acids dissolved in a suitable organic solvent, such as pyridine, dimethylacetamide or N-methylpyroli- ~ -done. As indicated above, the solvent is preferably removed prior to the final heat cure which drives off the water and ;
produces the intractable polyimide. The poly(amide-imide) resins are similar in chemical structure and may also be applied, in a polar solvent, in the amic acid form and ~ '~
subsequently cured to the insoluble, intractable form by thermally causing the loss of water.
As earlier indicated, application of the polymer solution can be by immersion, by spraying, by painting or by any other suitable method. The thickness of the cured polymer layer should be at least about 0.1 micron, and it is not considered necessary to use an intermediate layer thicker ;~
than about 25 micronsO Generally, the pclymer layer will be between about 0.2 and about 10 microns thick. Once the applica-tion is completed, the solvent is removed, preferably at a temperature below about 100C. and a smooth, continuous polymer film forms at the surface exposed to the atmosphere. Upon the conclusion of solvent removal, the temperature is raised to about 130C.-150C., and a final curiny is generally carried out at a temperature of about 225C. In the final baking process, the soluble, tractable polymer is converted to the insoluble, intractable, infusible polymer by the loss of water.

7~ ~ ~
Following the in situ heat treatment of the polymer layer, the pre-coated substrate is ready for the application of the biocompatible carbon coating. The carbon may be applied using standard VVD coating technology, operating at ;~
a vacuum of about 10 torr. Ion-plating, another vapor deposition process, is preferred, and may be carried out, for example, at about 10 to 20 microns pressure of argon, helium or some other suitable inert gas. In ion-plating~ the substrate is made a high-voltage sputtering cathode and is subjected to a flux of high energy ions from either a heated carbon source or a low pressure hydrocarbon gas during film formation.
The carbon coating should be at least about lOOOA
(0.1 micron) thick, and usually a thickness of more than about 12,000A is not needed. Generally, a coating thickness of about 4,000 to about 5,000A of dense carbon ~at least about 1.6 gram/cm3) is employed. Preferably, the vapor-deposited carbon has a density of at least about 1.8 g/cm3. Not only does such vapor-deposited carbon exhibit biocompatible properties substantially equivalent to that of isotropic pyrolytic carbon, but it also exhibits excellent adherence to the organic poly-meric intermediate layer or pre-coating which in turn is strongly bonded to the underlying metal alloy substrate. As a result, the coated and pre-coated substrate exhibits excellent `~
properties for use as a prosthetic device and is considered to be fully acceptable for implantation within the human body as a bone pin or replacement, as a part of a h~art valve, a dental implant or the like.
The following Example is exemplary of one method for making a prosthetic device embodying various features of the invention. ~owever, the Example should not be considered to plac~ any limitations upon the invention which is defined solely by the claims at the end of this specification.

_5_ ,: , ~03~
EXAMPLE
A valve housing for a Bjork heart valve~ made of Haynes alloy nu~ber 25 (a cobalt-base alloy) is cleaned by ultrasonic cleaning. The cleaned heart valve housing is immersed in a solution of Pyre-M.L. (Trade Mark), containing about 17 percent solids in an aromatic hydrocarbon solvent, a product of duPont Company. This polymer solution contains -~
polyamic acids formed by the reaction of aromatic diamines, such as 4,4'-Diaminodiphenyl ether, with pyromelletic dian-hydrides. The valve housing is removed from the pre-coating solution, drained and then dried for about 15 minutes at about 110C. in an air-circulating oven to drive off the major portion of the solvent and form a film at the surface. Heating is continued as the temperature is raised to about 140C. for .: .. . .
about 15 minutes and then to about 225C. for a final curing period of 60 minutes. Examination of the substrate shows a polyimide uniform continuous coating about 1.5 microns thick over the metal substrate. ';
The precoated substrate is transferred to an evaporative coater, and a vacuum of 10 5torr~ is established therein. A
crucible within the coater, filled with a commercial grade of artificial graphite, is heated by electron beam bombardment.

. : ~
Coating is carried out until a thickness of about 4500A of carbon is deposited. The carbon-coated valve body is removed ;
from the evaporative coater and examined. The exterior carbon layer is smooth and uniform and has a density of about 2.1 gm/cm . ~ ;
Testing of the valve casing establishes that the carbon coating is strongly adherent and can withstand the fluid forces involved. Previous testing had established that vapor-deposited carbon of this density, deposited under these con-ditions, was thromboresistant and fully compatible with body ,; ~, . . . .

tissue. The precoated, carbon~coated metal alloy substrate is considered to be excellently suited for use as a valve body for implantation in a human being.
Although the invention has been described with regard to certain preferred embodlments, it should be understood that ;:
modifications such as would be obvious to those having the ~ ~.
ordinary skill in this ar~ may be made without deviating from the scope of the invention which is defined in the appended ;-~
claims. For instance, in addition to metal alloy substrates, there may be advantages to employing the intermediate pre~
coating with other substrates for prosthetic devicea, for : example, ceram~cs, such as aluminum oxide, glass, quartz and the like.
Various features of the invention are ~et forth in the claims that follow. ~:

'': , ., . .~

.

Claims (12)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A biocompatible prosthetic device comprising a metal alloy substrate, an intermediate, continuous layer of an organic high-temperature polymer which is strongly bonded thereto, and an exterior in-situ-deposited coating of continuous dense vapor-deposited carbon at least 100.ANG. thick which carbon layer is biocompatible and strongly adherent to said intermediate layer.
2. A prosthetic device in accordance with Claim 1 wherein said high-temperature polymer consists essentially of a linear high-molecular-weight aromatic nitrogen-linked polymer.
3. A prosthetic device in accordance with Claim 1 wherein said high-temperature polymer is selected from the group consisting of ordered copolyamides, all-aromatic polybenzimid-azoles, polyoxadiazoles, poly(N-phenyl triazoles), polybenzo-benzimidazoles, polyimides and poly(amide-imide) resins.
4. A prosthetic device in accordance with Claim 1 wherein said polymer is a polyimide resin.
5. A prosthetic device in accordance with Claim 4 wherein said polymer is the reaction product of pyromelletic dianhydride and a diaminodiphenyl ether.
6. A prosthetic device in accordance with Claim 1 wherein said polymer is a poly(amide-imide) resin.
7. A prosthetic device in accordance with any one of Claims 1, 2 and 4 wherein said coating is not more than about 12,000.ANG. thick.
8. A method of making a biocompatible prosthetic device, which method comprises pre-coating a metal alloy sub-strate with an organic high-temperature polymer to provide a strongly adherent, continuous intermediate layer and then apply-ing carbon from a vaporous atmosphere to said pre-coated sub-strate to deposit a continuous, dense, thromboresistant carbon coating at least about 1000.ANG. thick upon said intermediate layer.
9. A method in accordance with Claim 8 wherein said polymer is a polyimide resin.
10. A method in accordance with Claim 9 wherein said polyimide is applied as a solution of a polyamic acid, wherein the major portion of the solvent is removed at a temperature below about 100°C. and wherein said curing to said polyimide form is carried out thereafter at a higher temperature.
11. A method in accordance with any one of Claims 8, 9 and 10 wherein said carbon is applied under high vacuum condi-tions by suitably heating a carbon source.
12. A method in accordance with any one of Claims 8, 9 and 10 wherein said carbon deposition is by ion-plating.
CA231,336A 1974-11-29 1975-07-14 Biocompatible carbon prosthetic devices Expired CA1038707A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/527,971 US3952334A (en) 1974-11-29 1974-11-29 Biocompatible carbon prosthetic devices

Publications (1)

Publication Number Publication Date
CA1038707A true CA1038707A (en) 1978-09-19

Family

ID=24103730

Family Applications (1)

Application Number Title Priority Date Filing Date
CA231,336A Expired CA1038707A (en) 1974-11-29 1975-07-14 Biocompatible carbon prosthetic devices

Country Status (8)

Country Link
US (1) US3952334A (en)
JP (1) JPS5178092A (en)
CA (1) CA1038707A (en)
DE (1) DE2553355A1 (en)
FR (1) FR2292460A1 (en)
GB (1) GB1527873A (en)
IT (1) IT1050315B (en)
SE (1) SE7513438L (en)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2603456C2 (en) * 1976-01-30 1984-04-05 Robert Bosch Gmbh, 7000 Stuttgart Process for the production of a bone implant
DE2619650C3 (en) * 1976-05-04 1985-06-05 Friedrichsfeld Gmbh, Steinzeug- Und Kunststoffwerke, 6800 Mannheim Dental implant
US4164794A (en) * 1977-04-14 1979-08-21 Union Carbide Corporation Prosthetic devices having coatings of selected porous bioengineering thermoplastics
US4149277A (en) * 1977-06-22 1979-04-17 General Atomic Company Artificial tendon prostheses
US4164045A (en) * 1977-08-03 1979-08-14 Carbomedics, Inc. Artificial vascular and patch grafts
US4204542A (en) * 1977-08-03 1980-05-27 Carbomedics, Inc. Multistrand carbon coated sutures
US4131957A (en) * 1977-08-12 1979-01-02 General Atomic Company Ball and socket prosthetic joint
US4351069A (en) * 1979-06-29 1982-09-28 Union Carbide Corporation Prosthetic devices having sintered thermoplastic coatings with a porosity gradient
DE3116026C2 (en) * 1981-04-22 1983-12-01 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Method for producing a biocompatible layer on vascular prostheses and device for carrying out the method
DE3116040C2 (en) * 1981-04-22 1983-04-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Biocompatible carbon layers for coating flexible materials and methods for applying the layers
IT1156484B (en) * 1982-08-03 1987-02-04 Sorin Biomedica Spa PROCEDURE FOR THE MANUFACTURE OF A PROTECTIVE DEVICE PROVIDED WITH A COATING OF BIOCOMPATIBLE CARBON MATERIAL AND PROTECTIVE DEVICE PROVIDED WITH SUCH A COATING
JPS5982851A (en) * 1982-11-04 1984-05-14 住友電気工業株式会社 Member for coated living body
CA1247960A (en) * 1983-03-24 1989-01-03 Hideki Aoki Transcutaneously implantable element
US4468309A (en) * 1983-04-22 1984-08-28 White Engineering Corporation Method for resisting galling
US5387247A (en) * 1983-10-25 1995-02-07 Sorin Biomedia S.P.A. Prosthetic device having a biocompatible carbon film thereon and a method of and apparatus for forming such device
US4698256A (en) * 1984-04-02 1987-10-06 American Cyanamid Company Articles coated with adherent diamondlike carbon films
JPS6266864A (en) * 1985-09-20 1987-03-26 呉羽化学工業株式会社 Implant material
US5013315A (en) * 1985-07-12 1991-05-07 Minnesota Mining And Manufacturing Company Semiabsorbable bone plate spacer
IL76079A (en) * 1985-08-13 1991-03-10 Univ Ramot Collagen implants
US5084151A (en) * 1985-11-26 1992-01-28 Sorin Biomedica S.P.A. Method and apparatus for forming prosthetic device having a biocompatible carbon film thereon
US4871366A (en) * 1986-05-27 1989-10-03 Clemson University Soft tissue implants for promoting tissue adhesion to same
US4846834A (en) * 1986-05-27 1989-07-11 Clemson University Method for promoting tissue adhesion to soft tissue implants
IT1196836B (en) * 1986-12-12 1988-11-25 Sorin Biomedica Spa Polymeric or metal alloy prosthesis with biocompatible carbon coating
IT1210722B (en) * 1987-05-11 1989-09-20 Sorin Biomedica Spa DEVICES FOR THE CONDITIONING OF BLOOD FLOWS
US7491205B1 (en) * 1988-06-13 2009-02-17 Warsaw Orthopedic, Inc. Instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the lateral aspect of the spine
US6123705A (en) * 1988-06-13 2000-09-26 Sdgi Holdings, Inc. Interbody spinal fusion implants
US5484437A (en) * 1988-06-13 1996-01-16 Michelson; Gary K. Apparatus and method of inserting spinal implants
US7534254B1 (en) 1988-06-13 2009-05-19 Warsaw Orthopedic, Inc. Threaded frusto-conical interbody spinal fusion implants
US5015247A (en) * 1988-06-13 1991-05-14 Michelson Gary K Threaded spinal implant
US6210412B1 (en) 1988-06-13 2001-04-03 Gary Karlin Michelson Method for inserting frusto-conical interbody spinal fusion implants
US6923810B1 (en) * 1988-06-13 2005-08-02 Gary Karlin Michelson Frusto-conical interbody spinal fusion implants
US6770074B2 (en) 1988-06-13 2004-08-03 Gary Karlin Michelson Apparatus for use in inserting spinal implants
CN1128944A (en) 1988-06-13 1996-08-14 卡林技术公司 Apparatus and method of inserting spinal implants
US7452359B1 (en) * 1988-06-13 2008-11-18 Warsaw Orthopedic, Inc. Apparatus for inserting spinal implants
US5772661A (en) * 1988-06-13 1998-06-30 Michelson; Gary Karlin Methods and instrumentation for the surgical correction of human thoracic and lumbar spinal disease from the antero-lateral aspect of the spine
US6120502A (en) * 1988-06-13 2000-09-19 Michelson; Gary Karlin Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis
US7431722B1 (en) * 1995-02-27 2008-10-07 Warsaw Orthopedic, Inc. Apparatus including a guard member having a passage with a non-circular cross section for providing protected access to the spine
US5609635A (en) * 1988-06-28 1997-03-11 Michelson; Gary K. Lordotic interbody spinal fusion implants
CA1322628C (en) * 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5207707A (en) * 1992-01-16 1993-05-04 Carbomedics, Inc. Tri-leaflet all carbon heart valve
CA2521196C (en) 1993-06-10 2007-04-17 Karlin Technology, Inc. Bone removal device for use in performing spinal surgery
CA2551185C (en) 1994-03-28 2007-10-30 Sdgi Holdings, Inc. Apparatus and method for anterior spinal stabilization
US5681657A (en) * 1995-02-02 1997-10-28 Rainer H. Frey Biocompatible porous hollow fiber and method of manufacture and use thereof
US5998024A (en) * 1995-02-02 1999-12-07 Rainer H. Frey Biocompatible material and method of manufacture and use thereof
US6758849B1 (en) 1995-02-17 2004-07-06 Sdgi Holdings, Inc. Interbody spinal fusion implants
CN1134810A (en) 1995-02-17 1996-11-06 索发默达纳集团股份有限公司 Improved interbody spinal fusion implants
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US7846202B2 (en) * 1995-06-07 2010-12-07 Cook Incorporated Coated implantable medical device
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US7867275B2 (en) * 1995-06-07 2011-01-11 Cook Incorporated Coated implantable medical device method
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
US7291149B1 (en) 1995-06-07 2007-11-06 Warsaw Orthopedic, Inc. Method for inserting interbody spinal fusion implants
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US6352543B1 (en) * 2000-04-29 2002-03-05 Ventrica, Inc. Methods for forming anastomoses using magnetic force
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
DE19855421C2 (en) * 1998-11-02 2001-09-20 Alcove Surfaces Gmbh Implant
US6187024B1 (en) 1998-11-10 2001-02-13 Target Therapeutics, Inc. Bioactive coating for vaso-occlusive devices
US8016852B2 (en) * 1998-11-10 2011-09-13 Stryker Corporation Bioactive components for incorporation with vaso-occlusive members
US6596084B1 (en) 1999-05-20 2003-07-22 Medicalcv, Inc. Pyrolytic carbon coating apparatus having feed gas actuator
US6761736B1 (en) 1999-11-10 2004-07-13 St. Jude Medical, Inc. Medical article with a diamond-like carbon coated polymer
CA2393330A1 (en) * 2000-01-25 2001-08-02 Boston Scientific Limited Manufacturing medical devices by vapor deposition
US7232449B2 (en) 2000-04-29 2007-06-19 Medtronic, Inc. Components, systems and methods for forming anastomoses using magnetism or other coupling means
US8518062B2 (en) 2000-04-29 2013-08-27 Medtronic, Inc. Devices and methods for forming magnetic anastomoses between vessels
US20050080439A1 (en) * 2000-04-29 2005-04-14 Carson Dean F. Devices and methods for forming magnetic anastomoses and ports in vessels
US7300662B2 (en) 2000-05-12 2007-11-27 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
EP1307142A4 (en) * 2000-08-12 2005-02-23 Ventrica Inc Processes for producing anastomotic components having magnetic properties
DE60124285T3 (en) 2000-09-29 2011-03-17 Cordis Corp., Miami Lakes COATED MEDICAL EQUIPMENT
US7803149B2 (en) 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
US7909837B2 (en) * 2000-12-13 2011-03-22 Medtronic, Inc. Methods, devices and systems for forming magnetic anastomoses
US8091556B2 (en) * 2001-04-20 2012-01-10 V-Wave Ltd. Methods and apparatus for reducing localized circulatory system pressure
US20050148925A1 (en) 2001-04-20 2005-07-07 Dan Rottenberg Device and method for controlling in-vivo pressure
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7727221B2 (en) 2001-06-27 2010-06-01 Cardiac Pacemakers Inc. Method and device for electrochemical formation of therapeutic species in vivo
US7351480B2 (en) * 2002-06-11 2008-04-01 Southwest Research Institute Tubular structures with coated interior surfaces
DE102005046333B3 (en) * 2005-09-27 2006-10-19 Viega Gmbh & Co. Kg Press-tool for connecting pipes has jaws whose rear ends can overlap as they are opened, allowing them to be used on large diameter pipes
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US9681948B2 (en) 2006-01-23 2017-06-20 V-Wave Ltd. Heart anchor device
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
CA2655793A1 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
JP2009545407A (en) 2006-08-02 2009-12-24 ボストン サイエンティフィック サイムド,インコーポレイテッド End prosthesis with 3D decomposition control
JP2010503469A (en) 2006-09-14 2010-02-04 ボストン サイエンティフィック リミテッド Medical device having drug-eluting film
JP2010503489A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Biodegradable endoprosthesis and method for producing the same
WO2008034066A1 (en) * 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
WO2008034013A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
DE602007011114D1 (en) 2006-09-15 2011-01-20 Boston Scient Scimed Inc BIODEGRADABLE ENDOPROTHESIS WITH BIOSTABILES INORGANIC LAYERS
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
US7981150B2 (en) * 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
ES2506144T3 (en) 2006-12-28 2014-10-13 Boston Scientific Limited Bioerodible endoprosthesis and their manufacturing procedure
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) * 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
WO2009012353A2 (en) 2007-07-19 2009-01-22 Boston Scientific Limited Endoprosthesis having a non-fouling surface
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
WO2009018340A2 (en) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
JP2010535541A (en) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
FR2928828B1 (en) * 2008-03-21 2010-04-02 Tornier Sa CARTILAGE RESURFACING IMPLANT
EP2271380B1 (en) 2008-04-22 2013-03-20 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
EP2303350A2 (en) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
EP2403546A2 (en) 2009-03-02 2012-01-11 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
EP2427143B1 (en) 2009-05-04 2017-08-02 V-Wave Ltd. Device for regulating pressure in a heart chamber
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
US10076403B1 (en) 2009-05-04 2018-09-18 V-Wave Ltd. Shunt for redistributing atrial blood volume
US20210161637A1 (en) 2009-05-04 2021-06-03 V-Wave Ltd. Shunt for redistributing atrial blood volume
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
US9629715B2 (en) 2011-07-28 2017-04-25 V-Wave Ltd. Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same
EP2999412B1 (en) 2013-05-21 2020-05-06 V-Wave Ltd. Apparatus for delivering devices for reducing left atrial pressure
WO2016178171A1 (en) 2015-05-07 2016-11-10 The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center Temporary interatrial shunts
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
WO2018158747A1 (en) 2017-03-03 2018-09-07 V-Wave Ltd. Shunt for redistributing atrial blood volume
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
WO2019142152A1 (en) 2018-01-20 2019-07-25 V-Wave Ltd. Devices and methods for providing passage between heart chambers
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US10898698B1 (en) 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
EP3972499A1 (en) 2019-05-20 2022-03-30 V-Wave Ltd. Systems and methods for creating an interatrial shunt
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
WO2023199267A1 (en) 2022-04-14 2023-10-19 V-Wave Ltd. Interatrial shunt with expanded neck region

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546711A (en) * 1968-04-09 1970-12-15 Gulf Energy & Environ Systems Heart valve
US3579645A (en) * 1969-04-30 1971-05-25 Gulf Energy & Environ Systems Cardiac valve occluder having a density approximately equal to blood
US3797113A (en) * 1970-06-01 1974-03-19 Vitredent Corp Dental implant
US3849887A (en) * 1970-06-01 1974-11-26 Vitredent Corp Dental implant
US3685059A (en) * 1970-07-28 1972-08-22 Gulf General Atomic Inc Prosthetic blood circulation device having a pyrolytic carbon coated blood contacting surface
US3707006A (en) * 1970-08-26 1972-12-26 Gulf Oil Corp Orthopedic device for repair or replacement of bone

Also Published As

Publication number Publication date
JPS5178092A (en) 1976-07-07
FR2292460A1 (en) 1976-06-25
GB1527873A (en) 1978-10-11
US3952334A (en) 1976-04-27
IT1050315B (en) 1981-03-10
SE7513438L (en) 1976-05-31
DE2553355A1 (en) 1976-08-12

Similar Documents

Publication Publication Date Title
CA1038707A (en) Biocompatible carbon prosthetic devices
US3677795A (en) Method of making a prosthetic device
US3526005A (en) Method of preparing an intravascular defect by implanting a pyrolytic carbon coated prosthesis
US5047054A (en) Triazine resin coated prosthetic implants
Galliano et al. Sol-gel coatings on 316L steel for clinical applications
AU2008312373B2 (en) Functionalized substrates with thin metal oxide adhesion layer
US5211833A (en) Method for coating implants and surgical devices made of titanium and titanium alloys
FI115445B (en) Bone replacement material and its manufacturing method
CA2563299C (en) Coated implants and methods of coating
EP2037980A1 (en) Calcium phosphate coated implantable medical devices, and electrochemical deposition processes for making same
WO1986002843A1 (en) A method of producing a mono- or multilayered prosthesis material and the material hereby obtained
US8313840B2 (en) Medical device having surface lubricity in wet state
CN108686267B (en) Coating with anticoagulation, anti-inflammation and anti-proliferation functions and preparation method thereof
CN114225124B (en) Ti-Cu/polydopamine composite coating with super-hydrophilicity and preparation method thereof
US6630460B2 (en) Heparin compositions and methods of making and using the same
Sangeetha et al. Biocompatibility studies on TiO 2 coated Ti surface
Langlet et al. Functionality of aerosol-gel deposited TiO2 thin films processed at low temperature
Wang et al. Biocompatibility study of plasma-coated nitinol (NiTi alloy) stents
Foruzanmehr et al. Nano-structure TiO2 film coating on 316L stainless steel via sol-gel technique for blood compatibility improvement
WO2002077073A2 (en) Plastic articles having a polyphosphazene coating
US20240110068A1 (en) Parylene-in-Oil Hydrophobic Coating
CN115708896B (en) Degradable magnesium alloy composite material and preparation method thereof
Jang et al. Fabrication and Evaluation of Polyelectrolyte Complexes of Dextran Derivatives for Drug Coating of Coronary Stents
CN114059131A (en) Magnesium/magnesium alloy material with photo-thermal antibacterial anticorrosive composite coating and preparation method thereof
Cao et al. Biomedical coatings prepared on carbon/carbon composites